Effects of common polymorphisms in the α1A-, α2B-, β1- and β2-adrenoreceptors on haemodynamic responses to adrenaline

Clinical Science

Volumn 104, Issue 5, 2003, Pages 509-520

  Snapir, Amir ^a   Koskenvuo, Juha ^b   Toikka, Jyri ^b   Orho Melander, Marju ^c   Hinkka, Susanna ^a   Saraste, Markku ^b   Hartiala, Jaakko ^b   Scheinin, Mika ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adrenaline; Adrenoreceptors; Genetics; In vivo; Polymorphism

Indexed keywords

ADRENALIN; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; NORADRENALIN; PROPRANOLOL; RECEPTOR SUBTYPE;

ADRENAL MEDULLA; ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR EFFECT; CATECHOLAMINE BLOOD LEVEL; CORONARY ARTERY BLOOD FLOW; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HEMODYNAMIC PARAMETERS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE RATE; TRANSTHORACIC ECHOCARDIOGRAPHY; VASOCONSTRICTION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CORONARY CIRCULATION; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EPINEPHRINE; GENOTYPE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; LEAST-SQUARES ANALYSIS; MALE; MULTIVARIATE ANALYSIS; NOREPINEPHRINE; POLYMORPHISM, GENETIC; PROPRANOLOL; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0038017249     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20020299     Document Type: Article

References (45)

1. 1-Adrenergic receptor regulation: basic science and clinical implications. Pharmacol. Ther. 88, 281-309
2. 2-adrenoceptors in normal and atherosclerotic human coronary circulation. Circulation 86, 1116-1124
3. Baumgart, D., Haude, M., Gorge, G. et al. (1999) Augmented α-adrenergic constriction of atherosclerotic human coronary arteries. Circulation 99, 2090-2097
4. 2-adrenergic receptor subtypes b and c. Science (Washington, D.C.) 273, 803-805
5. Rona, G. (1985) Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17, 291-306
6. 1-adrenergic receptor transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 96, 7059-7064
7. 2-adrenergic receptor on agonlst-mediated vascular desensitization. N. Engl. J. Med. 345, 1030-1035
8. 1A-Adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy. Br. J. Pharmacol. 118, 1403-1408
9. 1A-Adrenergic receptor polymorphism: association with ethnicity but not essential hypertension. Pharmacogenetics 9, 651-656
10. 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization. J. Biol. Chem. 276, 4917-4922
11. 2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects. J. Clin. Endocrinol. Metab. 84, 2429-2433
12. 2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events. J. Am. Coll. Cardiol. 37, 1516-1522
13. 2B-adrenoceptor gene as a risk factor for prehospital fatal myocardial infarction and sudden cardiac death. J. Am. Coll. Cardiol. 41, 190-194
14. 1-adrenergic receptor. J. Biol. Chem. 274, 12670-12674
15. 1-adrenergic receptor gene and hypertension. Circulation 104, 187-190
16. 1-adrenoceptor polymorphlsm varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11, 191-197
17. 1-adrenergic receptor is associated with resting heart rate. Am. J. Hum. Genet. 70, 935-942
18. 1-adrenoceptor polymorphism in humans. Pharmacogenetics 11, 199-205
19. 2-Adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin. Exp. Allergy 28, 442-448
20. 2-adrenergic receptor function. J. Allergy Clin. Immunol. 104, S42-S46
21. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33, 9414-9419
22. 2-Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33, 1425-1430
23. 2-Adrenoceptor polymorphlsm determines vascular reactivity in humans. Hypertension 36, 371-375
24. Illi, A., Sundberg, S., Ojala-Karlsson, P., Korhonen, P., Scheinin, M. and Gordin, A. (1995) The effect of entacapone on the disposition and hemodynamic effects of intravenous isoproterenol and epinephrine. Clin. Pharmacol. Ther. 58, 221-227
25. Karlsberg, R. P., Cryer, P. E. and Roberts, R. (1981) Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am. Heart J. 102, 24-29
26. Saraste, M., Koskenvuo, J., Knuuti, J. et al. (2001) Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin. Physiol. 21, 114-122
27. Hildick-Smith, D. J. and Shapiro, L. M. (1999) Potential use of transthoracic echocardiography in the assessment of coronary flow reserve. J. Am. Soc. Echocardiogr. 12, 590-595
28. Nuutila, P., Knuuti, M. J., Heinonen, O. J. et al. (1994) Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J. Clin. Invest. 93, 2267-2274
29. 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers. Life Sci. 49, 75-84
30. 1-adrenoceptor: identification and rapid screening assay. Lancet 353, 897
31. 2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37, 1303-1308
32. Parker, J. L., Oltman, C. L., Muller, J. M., Myers, P. R., Adams, H. R. and Laughlin, M. H. (1994) Effects of exercise training on regulation of tone in coronary arteries and arterioles. Med. Sci. Sports Exercise 26, 1252-1261
33. Talke, P. O., Lobo, E. P., Brown, R. and Richardson, C. A. (2001) Clonidine-induced vasoconstriction in awake volunteers. Anesth. Analg. 93, 271-276
34. Hughes, A. D., Thom, S. A., Martin, G. N. et al. (1988) Size and site-dependent heterogeneity of human vascular responses in vitro. J. Hypertens. 6, S173-S175
35. 1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. Clin. Sci. 99, 233-238
36. 1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am. J. Cardiol. 88, 1034-1037
37. 2-adrenoceptor stimulation in heart failure. J. Cardiovasc. Pharmacol. 16 (suppl. 5), S133-S137
38. Nakamaru, M., Jackson, E. K. and Inagami, T. (1986) β-Adrenoceptor-mediated release of angiotensin II from mesenteric arteries. Am. J. Physiol. 250, H144-H148
39. 2-Adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am. Heart J. 139, 537-542
40. Stein, C. M., Deegan, R. and Wood, A.J. (1997) Lack of correlation between arterial and venous β-adrenergic receptor sensitivity. Hypertension 29, 1273-1277
41. Langer, S. Z. (1980) Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32, 337-362
42. O'Sullivan, S. E. and Bell, C. (2000) The effects of exercise and training on human cardiovascular reflex control. J. Auton. Nerv. Syst. 81, 16-24
43. Tanaka, H., Reiling, M. J. and Seals, D. R. (1998) Regular walking increases peak limb vasodilatory capacity of older hypertensive humans: implications for arterial structure. J. Hypertens. 16, 423-428
44. Halbert, J. A., Silagy, C. A., Finucane, P., Withers, R. T., Hamdorf, P. A. and Andrews, G. R. (1997) The effectiveness of exercise training in lowering blood pressure: a meta-analysis of randomised controlled trials of 4 weeks or longer. J. Hum. Hypertens. 11, 641-649
45. Hansen, O., Johansson, B. W. and Nilsson-Ehle, P. (1990) Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective β adrenoceptor blockade. Angiology 41, 175-188